These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1706612)

  • 21. Mitogenesis and the search for new targets for anticancer drug design.
    Reeve JG
    Tumour Biol; 1991; 12(1):1-8. PubMed ID: 1996401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of drug inhibition of signalling molecules.
    Sebolt-Leopold JS; English JM
    Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early object relations into new objects.
    Downey TW
    Psychoanal Study Child; 2001; 56():39-67; discussion 68-75. PubMed ID: 12102023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ion channels for communication between and within cells.
    Neher E
    Science; 1992 Apr; 256(5056):498-502. PubMed ID: 1373906
    [No Abstract]   [Full Text] [Related]  

  • 25. Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling.
    Bianco R; Damiano V; Gelardi T; Daniele G; Ciardiello F; Tortora G
    Curr Pharm Des; 2007; 13(33):3358-67. PubMed ID: 18045190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cambridge Healthtech Institute Signal Transduction Conference: targets for effective therapeutics.
    Wong BR
    Expert Opin Investig Drugs; 2005 Feb; 14(2):209-14. PubMed ID: 15757398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microfilaments in cellular and developmental processes.
    Wessells NK; Spooner BS; Ash JF; Bradley MO; Luduena MA; Taylor EL; Wrenn JT; Yamada K
    Science; 1971 Jan; 171(3967):135-43. PubMed ID: 5538822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signalling via integrins: implications for cell survival and anticancer strategies.
    Hehlgans S; Haase M; Cordes N
    Biochim Biophys Acta; 2007 Jan; 1775(1):163-80. PubMed ID: 17084981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Informative aspects of interaction between regulatory peptides and cellular membranes].
    Mohylevych VR; Ostrovska HV; Rybalćhenko VK
    Fiziol Zh (1978); 1993; 39(5-6):86-92. PubMed ID: 8045323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.
    Noonberg SB; Benz CC
    Drugs; 2000 Apr; 59(4):753-67. PubMed ID: 10804033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of fatty acids in signal transduction: modulators and messengers.
    Sumida C; Graber R; Nunez E
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):117-22. PubMed ID: 7678706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.
    Favoni RE; de Cupis A
    Pharmacol Rev; 2000 Jun; 52(2):179-206. PubMed ID: 10835099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guanylyl cyclase in cell signalling.
    Thompson DK; Garbers DL
    Curr Opin Cell Biol; 1990 Apr; 2(2):206-11. PubMed ID: 1973047
    [No Abstract]   [Full Text] [Related]  

  • 34. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
    Wong MS; Sidik SM; Mahmud R; Stanslas J
    Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic protein kinase inhibitors.
    Grant SK
    Cell Mol Life Sci; 2009 Apr; 66(7):1163-77. PubMed ID: 19011754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erufosine: a membrane targeting antineoplastic agent with signal transduction modulating effects.
    Zaharieva MM; Konstantinov SM; Pilicheva B; Karaivanova M; Berger MR
    Ann N Y Acad Sci; 2007 Jan; 1095():182-92. PubMed ID: 17404031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key cancer cell signal transduction pathways as therapeutic targets.
    Bianco R; Melisi D; Ciardiello F; Tortora G
    Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of phosphatidylinositol signalling as antiproliferative agents.
    Powis G; Phil D
    Cancer Metastasis Rev; 1994 Mar; 13(1):91-103. PubMed ID: 8143348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ion channel activity and transmembrane signaling in lymphocytes.
    Damjanovich S; Pieri C; Trón L
    Ann N Y Acad Sci; 1992 Apr; 650():205-10. PubMed ID: 1376569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.